Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin A Derman

Showing results (21-30 of 54) with videos related to

Pageof 6
Sort By:
Leukemia & Lymphoma|November 5, 2019
Efficacy and toxicity of reduced vs. standard dose pegylated asparaginase in adults with Philadelphia chromosome-negative acute lymphoblastic leukemiaBenjamin A Derman, Mitchell Streck, Joseph Wynne, et al.
Blood Cancer Journal|August 10, 2020
Racial differences in treatment and outcomes in multiple myeloma: a multiple myeloma research foundation analysisBenjamin A Derman, Jagoda Jasielec, Spencer S Langerman, et al.
Blood Cancer Journal|October 7, 2024
Discontinuation of maintenance therapy in multiple myeloma guided by multimodal measurable residual disease negativity (MRD2STOP)Benjamin A Derman, Ajay Major, Jennifer Cooperrider, et al.
Cancers|November 11, 2022
Body Mass Index and Overall Survival of Patients with Newly Diagnosed Multiple MyelomaBei Wang, Benjamin A Derman, Spencer S Langerman, et al.
Blood Reviews|March 11, 2022
Reality check: Real-world evidence to support therapeutic development in hematologic malignanciesBenjamin A Derman, Andrew J Belli, Minoo Battiwalla, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 13, 2026
Diagnosis and Management of Multiple Myeloma With Central Nervous System InvolvementChristopher R D'Angelo, Benjamin A Derman, Srinivas Devarakonda, et al.
Blood Neoplasia|September 8, 2025
Minimal residual disease measurement in blood by mass spectrometry identifies long-term responders in multiple myelomaTadeusz Kubicki, Benjamin A Derman, Jennifer H Cooperrider, et al.
Blood Neoplasia|June 2, 2025
Population differences in the associations between chromosomal abnormalities and overall survival of multiple myelomaBei Wang, Benjamin A Derman, Madina Sukhanova, et al.
Breast Cancer Research and Treatment|June 14, 2013
Breast cancer in postmenopausal women after non-melanomatous skin cancer: the Women's Health Initiative observational studyMary Pressler, Carol A Rosenberg, Benjamin A Derman, et al.
European Journal of Haematology|February 2, 2023
A phase I study of selinexor combined with weekly carfilzomib and dexamethasone in relapsed/refractory multiple myelomaBenjamin A Derman, Ajai Chari, Jeffrey Zonder, et al.
Pageof 6

Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
Leukemia & Lymphoma|November 5, 2019
Efficacy and toxicity of reduced vs. standard dose pegylated asparaginase in adults with Philadelphia chromosome-negative acute lymphoblastic leukemiaBenjamin A Derman, Mitchell Streck, Joseph Wynne, et al.
Blood Cancer Journal|August 10, 2020
Racial differences in treatment and outcomes in multiple myeloma: a multiple myeloma research foundation analysisBenjamin A Derman, Jagoda Jasielec, Spencer S Langerman, et al.
Blood Cancer Journal|October 7, 2024
Discontinuation of maintenance therapy in multiple myeloma guided by multimodal measurable residual disease negativity (MRD2STOP)Benjamin A Derman, Ajay Major, Jennifer Cooperrider, et al.
Cancers|November 11, 2022
Body Mass Index and Overall Survival of Patients with Newly Diagnosed Multiple MyelomaBei Wang, Benjamin A Derman, Spencer S Langerman, et al.
Blood Reviews|March 11, 2022
Reality check: Real-world evidence to support therapeutic development in hematologic malignanciesBenjamin A Derman, Andrew J Belli, Minoo Battiwalla, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 13, 2026
Diagnosis and Management of Multiple Myeloma With Central Nervous System InvolvementChristopher R D'Angelo, Benjamin A Derman, Srinivas Devarakonda, et al.
Blood Neoplasia|September 8, 2025
Minimal residual disease measurement in blood by mass spectrometry identifies long-term responders in multiple myelomaTadeusz Kubicki, Benjamin A Derman, Jennifer H Cooperrider, et al.
Blood Neoplasia|June 2, 2025
Population differences in the associations between chromosomal abnormalities and overall survival of multiple myelomaBei Wang, Benjamin A Derman, Madina Sukhanova, et al.
Breast Cancer Research and Treatment|June 14, 2013
Breast cancer in postmenopausal women after non-melanomatous skin cancer: the Women's Health Initiative observational studyMary Pressler, Carol A Rosenberg, Benjamin A Derman, et al.
European Journal of Haematology|February 2, 2023
A phase I study of selinexor combined with weekly carfilzomib and dexamethasone in relapsed/refractory multiple myelomaBenjamin A Derman, Ajai Chari, Jeffrey Zonder, et al.
Pageof 6